NVST

Envista Holdings Corp
NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$3.85B
P/E Ratio
41.29
EPS
$0.58
Beta
0.86
52W High
$30.42
52W Low
$18.77
50-Day MA
$26.75
200-Day MA
$25.60
Dividend Yield
—
Profit Margin
3.33%
Forward P/E
16.81
PEG Ratio
—

About Envista Holdings Corp

Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$2.86B
Gross Profit (TTM)$1.58B
EBITDA$406.20M
Operating Margin10.40%
Return on Equity3.06%
Return on Assets3.23%
Revenue/Share (TTM)$17.41
Book Value$19.16
Price-to-Book1.24
Price-to-Sales (TTM)1.35
EV/Revenue1.501
EV/EBITDA10.19
Quarterly Earnings Growth (YoY)111.30%
Quarterly Revenue Growth (YoY)7.10%
Shares Outstanding$160.62M
Float$159.87M
% Insiders0.59%
% Institutions120.77%

Historical Volatility

HV 10-Day
40.53%
HV 20-Day
32.37%
HV 30-Day
28.53%
HV 60-Day
31.25%
HV Rank
18.7%

Volatility is currently expanding

Analyst Ratings

Consensus ($30.36 target)
1
Strong Buy
6
Buy
9
Hold

Latest News

NVST vs. ABT: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research9/25/2026Positive
Should Value Investors Buy Envista (NVST) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research9/18/2026Positive
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)

Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Investment Research9/18/2026Positive
Here's Why Envista (NVST) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research9/17/2026Positive
NVST or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research9/9/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NVST and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 9/26/2026